BioWorld

Jan. 29, 2004

View Archived Issues

Cytokinetics Files For IPO As Two Cancer Drugs Enter Clinic

With hopes of raising $86.25 million to advance two cancer drugs and a preclinical candidate for heart failure, Cytokinetics Inc. filed for its initial public offering. (BioWorld Today) Read More

Pozen Files Needed Rat Data For MT 100 NDA In Migraine

Read More

Original Carbon-14 Dating Limit Of 26,000 Years Reset At 50,000 Years To Be Future Evolutionary Yardstick

Read More

Genelabs Licenses Out Japanese Prestara Rights For Up To $12M

Read More

Other News To Note

Read More

Appointments And Advancements

Read More